lcp
We have detected you are using Internet Explorer. To provide the best and most secure experience, please use a modern browser as we do not support Internet Explorer.

Clinical Opal #7 - Ovarian cancer screening

22 October 2021 - Dr Simon Morgan

Anna Li, a 46 year old high school teacher, presents to you for follow up after a recent metatarsal fracture. At the end of the visit, she asks you whether she can be screened for ovarian cancer.

She tells you that one of the other teachers at her school had just been diagnosed and she has become aware that 'there is a blood test that can pick it up early'. She has been very worried about it since her colleague was diagnosed.

Anna is fit and well and has no symptoms on further questioning. She has no family history of breast or ovarian cancer. Her last CST was 2 years ago and normal.

How would you respond to Anna's request?

 

A clinical practice guideline published in JAMA in 2018 stated that there is clear evidence that screening for ovarian cancer does not reduce ovarian cancer mortality.1 Furthermore, there is evidence that the harms from screening for ovarian cancer can be substantial, including unnecessary surgery for women who have false positive tests. They concluded that the harms of screening for ovarian cancer outweigh the benefit.

This is reflected in the RACGP Guidelines for Preventive Activities in General Practice (Red Book)2 and in the recommendations of Choosing Wisely Australia.3

Anna should therefore be informed that screening for ovarian cancer in asymptomatic, low-risk women like herself is not recommended due to the low sensitivity and specificity of available tests. This requires a sensitive and patient-centred discussion on the benefits and harms of screening.

 

References

  1. US Preventive Services Task Force. Screening for Ovarian Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 2018.319;6:588-594.
  2. RACGP Preventive Activities in General Practice
  3. Choosing Wisely Australia website
Dr Simon Morgan
Dr Simon Morgan

Simon is a GP based in Newcastle, NSW, and a senior medical educator with Medcast.  He also has medical education roles with the RACGP and GPSA.

Over the past three decades, Simon has worked in clinical and educational roles in NSW and the NT, as well as in the Republic of Ireland. He has published over 75 peer reviewed journal articles, and in 2018 received the RACGP Corliss award for his contribution to medical education.

Simon is passionate about high quality education and training. He has particular interests in GP supervisor professional development and the rational use of tests and medicines. He is a proud member of Doctors for the Environment. He spends his spare time drinking craft beer and pretending that he is a musician in the Euthymics, an all-GP band.

Read more
Get Medcast Plus

Become a member and get unlimited access to 100s of hours of premium education.

Learn more
Latest News
Minimising risk of CLABSI - Standard or Surgical ANTT®?

Antiseptic Non-Touch Technique (ANTT®) plays a critical role in managing Central Venous Access Devices (CVADs) to prevent infections. While both standard and surgical ANTT approaches aim to maintain asepsis during procedures, they differ significantly in their application and outcomes. Understanding these distinctions ensures healthcare providers optimise infection control and patient safety in wound care and CVAD management.

5 mins READ
Launch of VETs HeLP: Veterans Healthcare eLearning Platform
Brand icon

Are you a general practitioner or health professional looking to enhance your knowledge and skills in treating veterans? Welcome to the VETs HeLP: Veterans Healthcare eLearning Platform.

Veterans’ mental health – an overview
Brand icon

Veteran mental illness can stem from military service experiences. PTSD, depression, anxiety and substance abuse are some of the outcomes experienced by veterans. These issues are exacerbated by reintegration challenges and perceived lack of support.

5 mins READ